Study Title

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Study Details

Description:

This is a Phase 3 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for confirming or excluding the presence of neuroblastoma

Sponsor:

Innervate Radiopharmacueticals LLC

Government Study Link:

NCT04724369 - Click here to see study on

ClinicalTrials.gov

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468